Literature DB >> 24271124

Effect of age on the disposition and tissue clearances of fluorinated pyrimidines in rats.

J L Au1.   

Abstract

The age dependency of the elimination and tissue clearances of 5-fluorouracil (FU) and its nucleoside analog, 5'-deoxy-5-fluorouridine (dFUR), was investigated in 2 to 12 months old female Fischer rats. In all age groups, the blood clearances of dFUR at infusion rates of 500 and 750 mg kg(-1) day(-1) and of FU at 25 and 35 mg kg(-1) day(-1) were independent of the dose; however, the clearance of FU at a higher infusion rate of 50 mg kg(-1) day(-1) was significantly lower than at 25 mg kg(-1) day(-1). An inverse relationship between animal age and clearance was observed for dFUR at both 500 and 750 mg kg(-1) day(-1) doses, and for FU at the 50 mg kg(-1) day(-1) dose. By contrast, the FU clearance at the 25 and 35 mg kg(-1) day(-1) doses was independent of age. To examine the age effect on the metabolic activities of major eliminating organs, the metabolism of dFUR by liver and small intestine in young and old rats was compared using 13,000 × g supernatant fractions of the tissue homogenates. Data were computer-fitted to the Michaelis-Menten equation. The Km for both tissues of both age groups was approximately 120 µg ml(-1). The intrinsic clearance (Vmax/Km) of dFUR was 5 ml kg(-1) min(-1) in the liver and 8 ml kg(-1) min(-1) in the intestine. The intestinal intrinsic clearance was independent of animal age, but the hepatic intrinsic clearance was significantly decreased in the older rats. The blood concentrations of FU derived as a metabolite from dFUR were also dependent on the animal age; an elevated FU concentration was associated with a lower dFUR metabolic clearance in the old rats. These data indicate that the elimination of FU and dFUR in rats is age-dependent, and that the systemic concentration of FU, a determinant of dFUR selectivity, is elevated in older animals.

Entities:  

Year:  1985        PMID: 24271124     DOI: 10.1023/A:1016389517202

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.

Authors:  R D Armstrong; R B Diasio
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

3.  Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.

Authors:  A Kono; Y Hara; S Sugata; Y Karube; Y Matsushima; H Ishitsuka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-01       Impact factor: 1.645

4.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

5.  Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.

Authors:  H Ishitsuka; M Miwa; K Takemoto; K Fukuoka; A Itoga; H B Maruyama
Journal:  Gan       Date:  1980-02

6.  Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.

Authors:  J L Au; J S Walker; Y Rustum
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

7.  Differential selectivity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in cultured human B lymphocytes and mouse L1210 leukemia.

Authors:  J L Au; Y M Rustum; J Minowada; B I Srivastava
Journal:  Biochem Pharmacol       Date:  1983-02-01       Impact factor: 5.858

8.  Regional and systemic serum concentrations of 5-fluorouracil after portal and intravenous infusion: an experimental study in dogs.

Authors:  B G Gustavsson; A Brandberg; C G Regårdh; O E Almersjö
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

9.  Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1980-04

10.  Phase I clinical study with 5'-deoxy-5-fluorouridine, a new fluoropyrimidine derivative.

Authors:  R Abele; P Alberto; R J Seematter; G Germano; R Heintz; W Bollag
Journal:  Cancer Treat Rep       Date:  1982-06
View more
  3 in total

1.  Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in rats.

Authors:  J L Au; M G Wientjes; S L Bramer
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.

Authors:  Y Sawai; K Yamaoka; T Nakagawa
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  Inhibition of intestinal pyrimidine nucleoside phosphorylases.

Authors:  M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.